Alexander Gilman
Examiner (ID: 6523, Phone: (571)272-2004 , Office: P/2831 )
Most Active Art Unit | 2833 |
Art Unit(s) | 2833, 2831 |
Total Applications | 3105 |
Issued Applications | 2518 |
Pending Applications | 101 |
Abandoned Applications | 486 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 19593150
[patent_doc_number] => 12150968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-26
[patent_title] => Method for reducing the transfer of pathogenic microorganisms
[patent_app_type] => utility
[patent_app_number] => 17/272640
[patent_app_country] => US
[patent_app_date] => 2019-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8341
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17272640
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/272640 | Method for reducing the transfer of pathogenic microorganisms | Aug 7, 2019 | Issued |
Array
(
[id] => 17168863
[patent_doc_number] => 20210322533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => VACCINE FORMULATIONS COMPRISING PRESERVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/261345
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17261345
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/261345 | VACCINE FORMULATIONS COMPRISING PRESERVATIVE | Jul 18, 2019 | Pending |
Array
(
[id] => 15083469
[patent_doc_number] => 20190336545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => Probiotic Prevention and Treatment of Colon Cancer
[patent_app_type] => utility
[patent_app_number] => 16/514796
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16514796
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/514796 | Probiotic prevention and treatment of colon cancer | Jul 16, 2019 | Issued |
Array
(
[id] => 17496513
[patent_doc_number] => 11285197
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Mesothelin vaccines and model systems
[patent_app_type] => utility
[patent_app_number] => 16/460993
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 43
[patent_no_of_words] => 28071
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16460993
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/460993 | Mesothelin vaccines and model systems | Jul 1, 2019 | Issued |
Array
(
[id] => 17170721
[patent_doc_number] => 20210324391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => RECOMBINANT MICROORGANISM, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PRODUCING COENZYME Q10
[patent_app_type] => utility
[patent_app_number] => 17/271356
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17271356
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/271356 | RECOMBINANT MICROORGANISM, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PRODUCING COENZYME Q10 | May 30, 2019 | Pending |
Array
(
[id] => 19410594
[patent_doc_number] => 12076386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Vaccine candidates against Johne's disease
[patent_app_type] => utility
[patent_app_number] => 16/422336
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19182
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16422336
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/422336 | Vaccine candidates against Johne's disease | May 23, 2019 | Issued |
Array
(
[id] => 15020905
[patent_doc_number] => 20190321457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => Methods for Enhancing Efficacy of a Vaccine by Administering an IL-4R Antagonist
[patent_app_type] => utility
[patent_app_number] => 16/398143
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16398143
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/398143 | Methods for Enhancing Efficacy of a Vaccine by Administering an IL-4R Antagonist | Apr 28, 2019 | Abandoned |
Array
(
[id] => 15035587
[patent_doc_number] => 20190328798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => MODULATION OF IMMUNE FUNCTION BY BACILLUS COAGULANS
[patent_app_type] => utility
[patent_app_number] => 16/396876
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396876
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/396876 | Modulation of immune function by | Apr 28, 2019 | Issued |
Array
(
[id] => 14621885
[patent_doc_number] => 20190224310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => MULTIVALENT GLYCOCONJUGATE VACCINES
[patent_app_type] => utility
[patent_app_number] => 16/379569
[patent_app_country] => US
[patent_app_date] => 2019-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16379569
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/379569 | Multivalent glycoconjugate vaccines | Apr 8, 2019 | Issued |
Array
(
[id] => 17420133
[patent_doc_number] => 11253562
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Feed supplement
[patent_app_type] => utility
[patent_app_number] => 16/379397
[patent_app_country] => US
[patent_app_date] => 2019-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 8059
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16379397
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/379397 | Feed supplement | Apr 8, 2019 | Issued |
Array
(
[id] => 14621883
[patent_doc_number] => 20190224309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => MULTIVALENT GLYCOCONJUGATE VACCINES
[patent_app_type] => utility
[patent_app_number] => 16/379049
[patent_app_country] => US
[patent_app_date] => 2019-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16379049
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/379049 | Multivalent glycoconjugate vaccines | Apr 8, 2019 | Issued |
Array
(
[id] => 15726775
[patent_doc_number] => 10611809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-07
[patent_title] => Single-domain antibody fusion proteins with the acid tail of alpha-synuclein
[patent_app_type] => utility
[patent_app_number] => 16/365900
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 3045
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16365900
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/365900 | Single-domain antibody fusion proteins with the acid tail of alpha-synuclein | Mar 26, 2019 | Issued |
Array
(
[id] => 15574069
[patent_doc_number] => 10577401
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Nucleic acids for single-domain antibodies with thermal stability under cytoplasmic expression
[patent_app_type] => utility
[patent_app_number] => 16/365945
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 3048
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16365945
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/365945 | Nucleic acids for single-domain antibodies with thermal stability under cytoplasmic expression | Mar 26, 2019 | Issued |
Array
(
[id] => 14893965
[patent_doc_number] => 20190290748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => ANTIGENS AND ANTIGEN COMBINATIONS
[patent_app_type] => utility
[patent_app_number] => 16/363799
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16363799
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/363799 | ANTIGENS AND ANTIGEN COMBINATIONS | Mar 24, 2019 | Abandoned |
Array
(
[id] => 16555746
[patent_doc_number] => 20210000894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => Anti-Stress Composition
[patent_app_type] => utility
[patent_app_number] => 16/982888
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8006
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982888
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/982888 | Anti-Stress Composition | Mar 24, 2019 | Abandoned |
Array
(
[id] => 15666421
[patent_doc_number] => 10597428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Compositions relating to a mutant clostridium difficile toxin and methods thereof
[patent_app_type] => utility
[patent_app_number] => 16/359267
[patent_app_country] => US
[patent_app_date] => 2019-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 56
[patent_no_of_words] => 61777
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16359267
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/359267 | Compositions relating to a mutant clostridium difficile toxin and methods thereof | Mar 19, 2019 | Issued |
Array
(
[id] => 17170774
[patent_doc_number] => 20210324444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => METHODS AND COMPOSITIONS FOR SELECTIVE CLEAVAGE OF NUCLEIC ACIDS WITH RECOMBINANT NUCLEASES
[patent_app_type] => utility
[patent_app_number] => 16/609705
[patent_app_country] => US
[patent_app_date] => 2019-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609705
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609705 | Methods and compositions for selective cleavage of nucleic acids with recombinant nucleases | Mar 14, 2019 | Issued |
Array
(
[id] => 17193155
[patent_doc_number] => 11161896
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Antibodies for detection of colistin-resistance
[patent_app_type] => utility
[patent_app_number] => 16/353467
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 10288
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353467
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/353467 | Antibodies for detection of colistin-resistance | Mar 13, 2019 | Issued |
16/332912 | BACTERIA | Mar 12, 2019 | Abandoned |
Array
(
[id] => 14833469
[patent_doc_number] => 20190275135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => VACCINES AGAINST INTRA-ABDOMINAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/351036
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16351036
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/351036 | VACCINES AGAINST INTRA-ABDOMINAL INFECTIONS | Mar 11, 2019 | Abandoned |